Provided by : LibreTexts
SUMMIT: Tirzepatide and heart failure with preserved ejection fraction SUMMIT (Packer et al., NEJM 2024, NEJMoa2410027, PMID 39555826) randomized 731 patients with heart failure with preserved ejection fraction (HFpEF) and a BMI 30 to tirzepatide up to 15 mg/week or placebo, with a median follow-up of 104 weeks
These combinations are often referred to as stacks, and several well-established protocols exist
Not only could their procedure effectively and simultaneously treat multiple lesions, it was also shown to treat kissing bone-on-bone lesions (not rare but serious injuries where there is damaged tissue on both sides of the bone joint)
Duncan, C
~ AlphaMD A complete month-by-month guide to building muscle, losing fat, and seeing real results A new year brings new opportunities, and if youve been thinking about making 2026 the year you finally get into the best shape of your life , youre not alone